ArticleOncotarget2019

Correction: Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma.

Roelants Caroline et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.